A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Radiopharm Theranostics, Ltd
Replimune Inc.
ImmunityBio, Inc.
Massive Bio, Inc.
University of Pittsburgh
Medicenna Therapeutics, Inc.
M.D. Anderson Cancer Center
Shattuck Labs, Inc.
Molecular Templates, Inc.
Institut Bergonié
Incyte Corporation